Medicine
CardioGen-82 150 mCi injection
CardioGen-82 150 mCi injection is a prescription medicine containing Rubidium chloride rb-82 for intravenous use, marketed by Bracco Diagnostics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store the generator at 20°C to 25°C (68°F to 77°F). Receipt, transfer…
Key facts
- Active ingredient (INN)
- Rubidium chloride rb-82
- Brand
- CardioGen-82
- Strength
- 150 mCi
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 injection
- Marketing authorisation holder
- Bracco Diagnostics
- Manufacturer
- Bracco Diagnostics
- Origin register
- US FDA, United States
- Storage
- Store the generator at 20°C to 25°C (68°F to 77°F). Receipt, transfer, possession, storage, disposal or use of this product is subject to the radioactive material regulations and licensing requirements of the U.S.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 December 1989
- Identifiers
- DailyMed set ID ee95aa18-9f2f-40eb-9b4c-583bea6f36bfNDC 0270-0091Application NDA019414
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 injection, solution in 1 package | 0270-0091-01 | Bracco Diagnostics | 30 December 1989 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 December 1989 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Rubidium chloride rb-82
Clinical summary
Rubidium chloride rb-82 is a radioactive diagnostic agent. It is available as injection for intravenous use. MedsAcross supplies Rubidium chloride rb-82 for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Rubidium chloride rb-82For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CardioGen-82 prescribing information (Bracco Diagnostics) · U.S. National Library of Medicine, DailyMed
Need CardioGen-82 150 mCi injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.